Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
4519:TYO
Chugai Pharmaceutical Co Ltd
JP¥8 245,00
+1,59%
(+129,00) 1D
1 Mei, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4519...
Open
JP¥8 529
High
JP¥8 893
Low
JP¥8 245
Mkt. cap
13,84 bn
Avg. vol.
3,04 m
Volume
5,93 m
Dividend
1,48%
Quarterly dividend
JPÂ¥31
Ex dividend date
29 Jun. 2026
P/E ratio
30,01
52-wk high
JP¥10 700
52-wk low
JP¥5 942
EPS
JPÂ¥275
Shares outstanding
547,19 m
No. of employees
5 k
News stories
From sources across the web
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5,1 k
Founded10 Mrt. 1925
Headquarters-
SectorPharmaceutical industry
Last report
24 Apr. 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
321,75 mjd/ (307,45 mjd est.)JPY
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
290,00 mjd
333,18 mjd
346,30 mjd
321,75 mjd
Cost of goods sold
88,07 mjd
100,24 mjd
87,56 mjd
92,79 mjd
Cost of revenue
88,07 mjd
100,24 mjd
87,56 mjd
92,79 mjd
Research and development expenses
45,66 mjd
48,60 mjd
52,41 mjd
41,89 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,41 mjd
27,89 mjd
36,92 mjd
28,90 mjd
Operating expense
65,24 mjd
76,45 mjd
89,74 mjd
70,19 mjd
Total operating expenses
153,31 mjd
176,69 mjd
177,30 mjd
162,98 mjd
Operating income
136,69 mjd
156,48 mjd
169,01 mjd
158,76 mjd
Other non operating income
-636,00 m
-356,00 m
994,00 m
1,43 mjd
EBT including unusual items
136,00 mjd
156,07 mjd
169,90 mjd
160,20 mjd
EBT excluding unusual items
136,00 mjd
156,07 mjd
169,90 mjd
160,20 mjd
Income tax expense
38,85 mjd
44,86 mjd
41,50 mjd
44,78 mjd
Effective tax rate
28,56%
28,74%
24,42%
27,95%
Other operating expenses
-8,83 mjd
-38,00 m
405,00 m
-596,00 m
Net income
97,16 mjd
111,21 mjd
128,41 mjd
115,42 mjd
Net profit margin
33,50%
33,38%
37,08%
35,87%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-54,00 m
-58,00 m
-95,00 m
-
Net interest expenses
-54,00 m
-58,00 m
-95,00 m
-
Depreciation and amortization charges
-
-
-
-
EBITDA
137,09 mjd
156,78 mjd
200,44 mjd
159,26 mjd
Gain or loss from assets sale
-
-
4,53 mjd
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more